Ashurst Perkins Coie advises Pacira BioSciences, Inc. on its $1.65 billion acquisition by Viatris Inc.
October 08, 2026
October 08, 2026
SEATTLE, Washington, Oct. 8 [Category: BizLaw/Legal] -- Ashurst Perkins Coie, a law firm, posted the following news:
* * *
Ashurst Perkins Coie advises Pacira BioSciences, Inc. on its $1.65 billion acquisition by Viatris Inc.
*
DENVER (October 8, 2026)--Ashurst Perkins Coie is pleased to have advised Pacira BioSciences, Inc. (Nasdaq: PCRX), a leader in innovative non-opioid pain therapies, on its $1.65 billion acquisition by Viatris Inc. (Nasda . . .
* * *
Ashurst Perkins Coie advises Pacira BioSciences, Inc. on its $1.65 billion acquisition by Viatris Inc.
*
DENVER (October 8, 2026)--Ashurst Perkins Coie is pleased to have advised Pacira BioSciences, Inc. (Nasdaq: PCRX), a leader in innovative non-opioid pain therapies, on its $1.65 billion acquisition by Viatris Inc. (Nasda . . .
